When you inject the medicine under your skin, nearly all of it enters your bloodstream and begins to work
Another condition that you should be aware of is pernicious anemia, an autoimmune condition commonly associated with Hashimotos thyroiditis and hypothyroidism
Sharing supply chain data with partners improves collaboration and leads to cost efficiencies
Right upper quadrant pain, fever, or yellowing of the skin/eyes (possible gallbladder disease) Extreme fatigue or weakness that interferes with daily activities Hair loss, brittle nails, or other signs of nutritional deficiency Symptoms of hypoglycaemia (particularly in patients taking insulin or sulfonylureas concurrently) New or worsening depression or anxiety related to eating difficulties Severe or ongoing constipation with abdominal distension Patients experiencing any of these symptoms should contact their GP promptly
Over time, patients may continue using Tirzepatide for up to a year or longer, depending on how well they are responding to the medication and whether they have achieved their desired weight loss